| Expression pattern: |
DN |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
May serve as a plasma biomarker reflecting malignancy stage and predicting better response to induction chemotherapy; decreased levels associated with late-stage OSCC and second primary OSCC risk. |
| Molecular mechanism: |
not specified |
| Biological pathway or process: |
drug response (other) |
| Detected method: |
Q
|
| Validation methods: |
divergent primers PCR; RNase R Treatment; Sanger Sequencing; RT-qPCR; Clinical Sample Validation; ROC Analysis; Survival Analysis; Cohort Study; Transfection |
| Clinical significance: |
Decreased plasma hsa_circ_0000190 is associated with late-stage OSCC and may help differentiate OSCC patients from healthy individuals; high/ascending plasma hsa_circ_0000190 may predict better response to induction chemotherapy. |
| Description: |
hsa_circ_0000190 is decreased in OSCC patient plasma, especially in late-stage disease, and shows diagnostic utility. Higher/ascending plasma levels may indicate a better response to induction chemotherapy and lower levels may associate with second primary OSCC risk. |
| Confidence score: |
0.7322 |